Document is current

Article History

Accepted: 18 March 2025

First Online: 15 April 2025

Declarations

:

: Open access funding provided by Université de Toulouse.

: P.G. reports a relationship with French Federation of Cardiology that includes: funding grants. M.E. reports a relationship with Abott, Boston, Lilly, Amgen, Sanofi, AstraZeneca, Boehringer Ingelheim, Novo Nordisk and Novartis that includes: board membership, consulting or advisory, and speaking and lecture fees. F.B. reports a relationship with Boston, Abbott and CoreAalst BV that includes: consulting or advisory and speaking and lecture fees. The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The research grant had no role in the design and conduct of this study; collection, management, analysis, interpretation of the data; preparation, and decision to submit the manuscript. No other potential conflicts of interest relevant to this article were reported.

: Not applicable.

: Not applicable.

: Not applicable.

: Data cannot be shared publicly nor by request to the corresponding author as Vigibase® data are only available with permission from Uppsala Monitoring Center.

: Not applicable.

: P.G. and F.M. researched data and performed statistical analyses. P.G. wrote the first draft of the manuscript. P.G., F.M., M.E., F.B. and F.D. contributed to discussion, reviewed and edited the manuscript. All authors approved the final version of the manuscript. P.G. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.